Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2356 AL 2370

Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation

Tajima Y, Mito Y, Yanai M, Fukazawa Y.

BMJ Case Rep. 2012 Sep 3;2012:bcr2012006522. doi: 10.1136/bcr-2012-006522.

Trends and issues in characterizing early cognitive changes in Parkinson's disease

Claassen DO, Wylie SA.

Curr Neurol Neurosci Rep. 2012 Dec;12(6):695-702. doi: 10.1007/s11910-012-0312-5.

The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism

Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK.

Int J Mol Sci. 2012;13(8):10478-10504. doi: 10.3390/ijms130810478. Epub 2012 Aug 21.

Innate inflammation in Parkinson's disease

Perry VH.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a009373. doi: 10.1101/cshperspect.a009373.

Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways

Cookson MR.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a009415. doi: 10.1101/cshperspect.a009415.

Othello syndrome secondary to ropinirole: a case study

Pal K, Smith A, Hayes J, Chakraborty A.

Case Rep Psychiatry. 2012;2012:353021. doi: 10.1155/2012/353021. Epub 2012 Jun 24.

What is the most promising treatment for Parkinson's disease: genes, cells, growth factors or none of the above?

Cummins G, Barker RA.

Regen Med. 2012 Sep;7(5):617-21. doi: 10.2217/rme.12.47.

Painful cervical dystonia triggered by the extension wire of a deep brain stimulator

Spagnolo F, Picozzi P, Franzin A, Martinelli V, Comi G, Volonte MA.

J Clin Neurosci. 2012 Nov;19(11):1582-3. doi: 10.1016/j.jocn.2011.11.040. Epub 2012 Sep 3.

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease

Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR.

Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6.

Short circuit in deep brain stimulation

Samura K, Miyagi Y, Okamoto T, Hayami T, Kishimoto J, Katano M, Kamikaseda K.

J Neurosurg. 2012 Nov;117(5):955-61. doi: 10.3171/2012.8.JNS112073. Epub 2012 Sep 7.

5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds

Ivachtchenko AV, Ivanenkov YA, Skorenko AV.

Expert Opin Ther Pat. 2012 Oct;22(10):1123-68. doi: 10.1517/13543776.2012.722205. Epub 2012 Sep 7.

A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China

Nie K, Zhang Y, Wang L, Zhao J, Huang Z, Gan R, Li S, Wang L.

J Clin Neurosci. 2012 Nov;19(11):1497-500. doi: 10.1016/j.jocn.2011.11.039. Epub 2012 Sep 6.

Animal models of Parkinson's disease: vertebrate genetics

Lee Y, Dawson VL, Dawson TM.

Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a009324. doi: 10.1101/cshperspect.a009324.

Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson's disease: potential therapeutic targets?

Jiang TF, Chen SD.

Neurosci Bull. 2012 Oct;28(5):649-57. doi: 10.1007/s12264-012-1263-1. Epub 2012 Sep 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias